SB 608 — Maryland
Maryland Medical Assistance Plan and Health Insurance - Pharmacogenomic Testing - Required Coverage
Requiring, beginning July 1, 2027, the Maryland Medical Assistance Program and certain health insurers, nonprofit health services plans, and health maintenance organizations to provide coverage for single-gene and multigene pharmacogenomic testing in certain circumstances.
Latest action: Hearing 4/02 at 1:00 p.m. · Mar 25, 2026
Synopsis written by the legislature's own staff, as published on the official bill page. Status label is derived from the recorded actions. The full text below is the record.
Committees: Finance (Senate); Health (House of Delegates)
Updated Apr 2, 2026
Timeline
First Reading Finance
Feb 5, 2026 · Senate
Hearing 3/04 at 1:00 p.m.
Feb 12, 2026 · Senate
Favorable with Amendments Report by Finance
Mar 20, 2026 · Senate
Favorable with Amendments {
Mar 20, 2026 · Senate
Second Reading Passed with Amendments
Mar 20, 2026 · Senate
Third Reading Passed
Mar 20, 2026 · Senate
Referred Health
Mar 23, 2026 · House of Delegates
Hearing 4/02 at 1:00 p.m.
Mar 25, 2026 · House of Delegates
Sponsored by Johnny Mautz
Senate vote — 39–0
On Third Reading · Mar 5, 2026 · result: pass
39 yea · 0 nay · 8 absent, excused, abstain or not voting
How we know this
Every line above comes from the Maryland General Assembly record via Open States. The motion text is shown as recorded, so a procedural vote (to amend, refer or reconsider) is not read as a vote on the bill itself. The source does not say which text version each vote was on; every version is linked below.
Official records. Maryland legislators, bills and roll-call votes from the Maryland General Assembly, imported through Open States on Oct 29, 2026. Accuracy review against the official site is still under way. Campaign-finance records for Maryland are not imported yet.